Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

Healthcare Cannabis
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Medipharm Labs Corp > TGA approves CBD down scheduling.
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(5)
•••
Comment by Lemoyneon Dec 16, 2020 2:02pm
96 Views
Post# 32120170

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:TGA approves CBD down scheduling.

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:TGA approves CBD down scheduling.Ok, just to put emerald 100 cbd (20ml) in perspective.

Cortalex sells 100 cbd on shoppers but in 30ml quantities so 3000mg vs 2000mg for emerald (1.5x). So Cortalex sells 1.5x amount of cbd for 400$.

https://cannabis.shoppersdrugmart.ca/en_CA/products/Cortalex-Cardiol-Therapeutics-Cortalex-100-CBD-Oil-Hybrid/222

Emerald: 90 bucks for 2000mg =135 for 3000mg, so you're looking at almost 70% discount compared to cortalex 100 cbd.

Granted, cortalex is very steeply priced but even compared to labs cbd 50, it would cost 235$ for 3000mg, and that is still a 40-45% discount if you buy emerald

And emerald has less margins because they go through valens. Doesn't look profitable
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities